From clinical development to post-approval research, let us help you ensure the safety of your patients by examining and understanding disease indicators and the real-world usage and effects of your drug.
To understand disease distribution, risk factors, treatment patterns and impact, comorbidities, burden-of-illness, other related factors, and the effectiveness of risk minimization interventions, our international and expert team of epidemiologists can help you ask the right questions and apply the right methodologies to yield meaningful and actionable evidence.
Whether you’re looking for consulting advice; database, registry or prospective observational research; a literature review; or a risk management plan, we can provide you with high-quality, scientifically-rigorous, and publication-ready epidemiology support.
Rely On Our Experts
For example, Dr. Elizabeth Andrews serves as the vice-chair of the Steering Committee of the Innovation in Medical Evidence Development and Surveillance (IMEDS) program, Dr. Susana Perez-Gutthann is member of the Steering Committee and Dr. Alejandro Arana chairs the Research Standards Working Group of the European Network of Centre for Pharmacoepidemiology and Pharmacovigilance (ENCePP), and Prof. Kenneth Rothman teaches at many academic programs and is editor and co-author of Modern Epidemiology, one of the most frequently-cited textbooks in epidemiology research methods. Several colleagues also maintain appointments at the University of North Carolina School of Public Health and School of Pharmacy, Boston University, the Harvard School of Public Health, and the University of Dundee.
Members of our team have played key roles in our professional society, the International Society for Pharmacoepidemiology (ISPE), including 2 Presidents, 6 members for the Board of Directors, and chairs of various Committees. Through its Barcelona based team, we are also a member of the ENCePP research network and a research site in the two major EU funded research consortia.